Specific treatment of ATTR‑CM in Germany – expert consensus of the German Society of Amyloid Diseases (DGAK) and German Cardiac Society (DGK) AndreaSaidi2026-11-12T13:29:30+01:00 Weiterlesen
Disease modifying treatment of hereditary transthyretin amyloidosis with polyneuropathy in Germany – expert consensus of the German society of amyloid diseases (DGAK) and the German neurological society (DGN) AndreaSaidi2026-11-12T13:35:53+01:00 Weiterlesen
Teclistamab in relapsed/refractory light chain amyloidosis: A retrospective multicenter study by the German Society for Amyloid Diseases AndreaSaidi2026-11-12T13:35:17+01:00 Weiterlesen
February 2027 17-19th – New Amyloidosis Meeting: The molecular foundations of systemic amyloidoses and beyond AndreaSaidi2026-11-12T12:52:38+01:00 Weiterlesen
10.–13. April 2027 – 133. Kongress der Deutschen Gesellschaft für Innere Medizin AndreaSaidi2026-11-12T13:53:53+01:00 Weiterlesen
